Related Experiment Video
Updated: Dec 28, 2025
08:36
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
11.6K
A synopsis of prostate organoid methodologies, applications, and limitations
Anna M Gleave1, Xinpei Ci1,2, Dong Lin1,2
1Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
The Prostate
|February 22, 2020
Summary
Prostate cancer (PCa) organoid models offer a more biologically relevant in vitro system. These 3D cultures capture tumor diversity and can advance drug development and precision oncology for PCa.
Area of Science:
- Oncology
- Biomedical Engineering
- Cancer Research
Background:
- Current in vitro models lack the biological and clinical diversity of prostate cancer (PCa).
- Organoids are 3D in vitro cultures that mimic prostate cancer heterogeneity, architecture, and tumor characteristics.
Purpose of the Study:
- To review cutting-edge prostate organoid methodologies, applications, and limitations.
- To enhance the utility of organoid models in prostate cancer research.
Main Methods:
- Summarize methods for establishing benign and PCa organoids.
- Describe practical applications and challenges of organoid models.
- Highlight the patient-derived xenograft (PDX)-organoid interface model for rare PCa subtypes.
Main Results:
- Organoid models recapitulate prostate cancer heterogeneity and architecture.
- The PDX-organoid interface model facilitates organoid generation from diverse PCa subtypes.
- Organoids serve as a quasi in vivo preclinical model for PCa research.
Conclusions:
- Organoids are amenable to genetic modification and functional studies.
- Future research should refine culturing conditions to improve drug response fidelity.
- The PDX-organoid interface model may enable the establishment of rare PCa subtype organoid lines.
